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embryonic endoderm (Sox7, Afp, Sdf1)-, mesoderm (Foxf1, 
Meox1)- and ectoderm (Pax6, NeuroD6)-specific transcripts. 
The presence of Hnf4  , Hes1 and Pdx1 mRNA demonstrated 
the expression of primitive gut/foregut cell-specific markers. 
Ngn3, Nkx6.1 and Nkx2.2 transcripts in Sox17-positive cells 
were determined as properties of pancreatic endocrine pro-
genitors. Immunocytochemistry of activin A-induced Sox17-
positive embryoid bodies revealed coexpression of Cxcr4 
and Foxa2. Moreover, the histochemical demonstration of 
E-cadherin-, Cxcr4-, Sox9-, Hnf1  - and Ngn3-positive epithe-
lial-like structures underlined the potential of Sox17-positive 
cells to further differentiate into the pancreatic lineage. By 
reducing the heterogeneity of the ES cell progeny, Sox17-
expressing cells are a suitable model to evaluate the effects 
of growth and differentiation factors and of culture condi-
tions to delineate the differentiation process for the genera-
tion of pancreatic cells in vitro. 
 Copyright © 2011 S. Karger AG, Basel 
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 Abstract 
 Embryonic stem (ES) cells offer a valuable source for generat-
ing insulin-producing cells. However, current differentiation 
protocols often result in heterogeneous cell populations of 
various developmental stages. Here we show the activin A-
induced differentiation of mouse ES cells carrying a homolo-
gous dsRed-IRES-puromycin knock-in within the  Sox17 locus 
into the endoderm lineage. Sox17-expressing cells were 
 selected by fluorescence-assisted cell sorting (FACS) and 
characterized at the transcript and protein level. Treatment 
of ES cells with high concentrations of activin A for 10 days 
resulted in up to 19% Sox17-positive cells selected by FACS. 
Isolated Sox17-positive cells were characterized by defini-
tive endoderm-specific Sox17/Cxcr4/Foxa2 transcripts, but 
lacked pluripotency-associated Oct4 mRNA and protein. The 
Sox17-expressing cells showed downregulation of extra-
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 Introduction 
 The increasing incidence of diabetes mellitus and the 
shortage of transplantable pancreatic islets to treat pa-
tients suffering from the disease require alternative meth-
ods to generate insulin-producing cells of a sufficient 
amount and quality [Guo and Hebrok, 2009]. Due to their 
almost unlimited replication potential and ability to form 
all differentiated cell types of the body [Wobus and Bohe-
ler, 2005], embryonic stem (ES) cells have been used to 
generate insulin-producing cells in vitro. Initially, the fol-
lowing strategies were applied: (1) the directed differentia-
tion through lineage selection of pancreatic phenotypes 
using pancreas-specific promoters [Leon-Quinto et al., 
2004; Soria et al., 2000], (2) the constitutive expression of 
pancreatic developmental control genes [Blyszczuk et al., 
2003; Ku et al., 2004; Miyazaki et al., 2004; Shiroi et al., 
2005; Treff et al., 2006; Boretti and Gooch, 2007; Serafimi-
dis et al., 2008], (3) the application of specific signaling 
molecules, such as phosphoinositide 3-kinase inhibitors 
[Hori et al., 2002] or retinoic acid [Micallef et al., 2005; Shi 
et al., 2005; McKiernan et al., 2007], (4) the differentia-
tion via multilineage progenitors [Blyszczuk et al., 2004;
Schroeder et al., 2006], (5) the use of conditioned medium 
from fetal pancreatic buds [Vaca et al., 2006] and (6) the 
selection and enrichment of a nestin-expressing cell popu-
lation [Lumelsky et al., 2001]. However, in these earlier 
studies using mouse ES cells, differentiation was insuffi-
cient with respect to the number of insulin-positive cells 
and their maturation status, and in many cases, insulin-
producing neural progeny rather than pancreatic cells 
were generated [Rajagopal et al., 2003; Hansson et al., 
2004; Sipione et al., 2004; Hori et al., 2005; Roche et al., 
2005].
 A prerequisite for pancreatic differentiation is the for-
mation of definitive endoderm (DE), which in turn gives 
rise to the pancreatic lineage. A crucial transcription fac-
tor governing DE development is Sox17, as underlined by 
a lack/depletion of gut formation in Sox17-null mutant 
mice [Kanai-Azuma et al., 2009]. In vivo, the generation 
of DE is induced via nodal signaling [Tam et al., 2003; 
Grapin-Botton and Constam, 2007; Tam and Loebel, 
2007], a member of the transforming growth factor-  
superfamily. Activin A mimicking nodal signaling [Tam 
et al., 2003] has been shown to specifically induce differ-
entiation of ES cells into DE [Kubo et al., 2004; D’Amour 
et al., 2005; Shi et al., 2005; Cai et al., 2007]. However, 
several critical culture parameters have to be considered 
that vary between human and murine ES cells, i.e. se-
rum- and feeder-free cell culture and the concentration, 
time and duration of activin A application [Sulzbacher 
et al., 2009]. 
 In vitro, activin A [D’Amour et al., 2006; Jiang et al., 
2007; Kroon et al., 2008] was successfully applied to hu-
man and murine ES cells to generate DE, and by consec-
utive application of differentiation factors, to derive pan-
creatic cells. However, the current differentiation proto-
cols resulted in a heterogeneous population containing 
cells of various developmental stages including undiffer-
entiated pluripotent, potentially tumorigenic stem cells 
and a remarkable number of nonpancreatic cells. The se-
lection of a homogeneous population of DE progenitors 
will be one prerequisite for efficient pancreatic differen-
tiation [McKnight et al., 2010]. Such selection was at-
tempted by Tada et al. [2005], who used  goosecoid ( Gsc ) 
expression as a marker for mesendodermal cells. They 
identified Gsc + /E-cadherin + /PDGFR  – cells as inter-
mediates that would eventually differentiate into DE
and could be distinguished from Gsc + /E-cadherin – /
PDGFRa + mesoderm. Similarly, Cai et al. [2010] sorted 
activin A-induced cells using Cxcr4 as a marker to obtain 
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a homogeneous Pdx1 + population upon further differen-
tiation with retinoic acid. However, like Gsc, Cxcr4 is a 
marker of mesoderm, endoderm and their mesendoder-
mal precursors.
 Here, we present the activin A-induced differentiation 
of murine ES cells that carry a homologous dsRed-inter-
nal ribosomal entry site (IRES)-puromycin knock-in 
within the  Sox17 locus, followed by fluorescence-assisted 
cell sorting (FACS) selection of Sox17-positive DE cells 
and analysis of their transcript levels, protein abundance 
and cellular localization.
 Materials and Methods 
 Generation of Sox17-dsRed Knock-In ES Cells and Culture of 
Undifferentiated ES Cells 
 Feeder-free CGR8 ES cells carrying a homologous dsRed-
IRES-puromycin knock-in within the  Sox17 gene locus were used. 
The strategy for generating the dsRed-IRES-puromycin knock-in 
cell line involved the generation of the targeting construct, the 
modification of a mouse bacterial artificial chromosome clone 
encompassing the  Sox17 locus by recombineering in  Escherichia 
coli [Zhang et al., 2000] and subcloning of the modified  Sox17 lo-
cus, followed by homologous recombination in ES cells. Correct-
ly targeted ES cells were identified by Southern blotting [unpubl. 
data]. dsRed expression allowed real-time identification, selection 
and characterization of Sox17-positive DE progenitors by FACS. 
In further studies, resistance to puromycin would permit the se-
lective isolation and cultivation of DE cells.
 The Sox17-dsRed ES cells were maintained on gelatine 
(0.1%)-coated tissue culture dishes in Glasgow minimum essen-
tial medium ES cell culture medium (Invitrogen) supplemented 
with 10% fetal calf serum (FCS), nonessential amino acids (1: 100), 
2 m M  L -glutamine, 1 m M sodium pyruvate, penicillin/streptomy-
cin (all Invitrogen), 100   M   -mercaptoethanol (Merck), 10 ng/
ml leukemia inhibitory factor (Millipore) and 200   g/ml G418 
(Calbiochem). Cultures were passaged every day at a 1: 3 split ratio 
[Wobus et al., 2002; Blyszczuk et al., 2006].
 Differentiation of ES Cells 
 For differentiation, ES cells were washed 2 times with serum-
free chemically defined medium (CDM) [Johansson and Wiles, 
1995]. Basal CDM was prepared from Iscove’s modified Dulbec-
co’s medium (IMDM) with Glutamax-I and Ham’s F12 medium 
(F12) with Glutamax-I (both Invitrogen, 1: 1) supplemented with 
450   M monothioglycerol, 2 U/ml leukemia inhibitory factor, 1% 
chemically defined lipid concentrate (Invitrogen), 5 mg/ml bo-
vine serum albumin (BSA, Sigma), 150   g/ml transferrin (Sigma) 
and 7   g/ml insulin (Sigma).
 Embryoid bodies (EBs) were formed as hanging drops (600 
cells/20   l) for 3 days and subsequently cultured in bacteriologi-
cal dishes for 4–7 days.
 For the induction of endoderm differentiation, 50 and 100 ng/
ml activin A (R&D Systems, PeproTech), respectively, were added. 
Control EBs were cultured in CDM alone, CDM supplemented 
with 20% FCS with or without activin A and in IMDM/F12 sup-
plemented with 2 m M glutamine, nonessential amino acids
(1: 100), penicillin/streptomycin, 450   M monothioglycerol and 
20% FCS. To analyze the specificity of the activin A treatment, a 
subset of cells was additionally treated with 5   M SB431542, an 
inhibitor of transforming growth factor-  1 superfamily activin 
receptor-like kinase (ALK) receptors, in CDM + 50 ng/ml activin 
A. The morphology of the cells was analyzed by the Eclipse T300 
microscope (Nikon). The data presented here are based on 7 in-
dependent experiments.
 Flow Cytometry and Cell Sorting 
 Cells of EBs were dissociated with 0.08% EDTA/0.5% trypsin 
(1: 1) at room temperature (RT) for 3 min. The reaction was 
stopped with serum-containing medium. After washing with 
PBS, the cell suspension was collected in 0.75 ! PBS at 4   °   C, fil-
tered through a 50-  m mesh, stained with propidium iodide (PI) 
(1   g/ml) and analyzed within 1 h by a FACSAria flow sorter (BD 
Biosciences) equipped with a 488-nm laser. For detection of 
dsRed, PI and FITC the following filters were used: 575/26, 610/20 
and 539/30, respectively. Sorting was performed in 0.75  ! PBS 
and the data processed using the Diva Software (BD Biosciences).
 Reverse Transcription PCR 
 Total RNA was extracted with RNeasy Mini Kit (Qiagen) fol-
lowed by cDNA synthesis using reverse transcription system (Fer-
mentas) according to the manufacturer’s recommendations.
 Quantitative Real-Time PCR 
 For real-time PCR of cells at defined time points during dif-
ferentiation and of FACS-sorted Sox17-positive and Sox17-nega-
tive cells, the mRNA was isolated with DynaBeads mRNA direct 
Micro Kit (Invitrogen) followed by DNase treatment (Abcam) and 
cDNA synthesis using a reverse transcription system (Fermentas) 
according to the manufacturer’s recommendations. Changes in 
mRNA levels of specific genes were quantified using the ABI 
PRISM 7900HT Sequence Detection System and the Step One 
Plus (Applied Biosystems). A set of specific oligonucleotide prim-
ers was designed using Primer Express software 2.0 (Applied Bio-
systems). Amplification of the target genes was monitored via 
SYBR green fluorescence signals generated during each PCR cy-
cle. Fluorescence signals were regarded as positive, if the fluores-
cence intensity reached 10 ! the standard deviation of the base-
line fluorescence (threshold). The amplification mix was pre-
pared following the SYBR green PCR Master Mix (Applied 
Biosystems) protocol. Each reaction was performed in triplicate 
in 96-well optical reaction plates under the following conditions: 
50  °  C for 2 min, 95  °  C for 10 min, followed by 50 cycles of 95  °  C for 
15 s (denaturation) and 60   °   C for 1 min (annealing/extension). 
Relative mRNA levels were calculated using the standard curve 
method (see ABI PRISM 7700 Sequence Detection System User 
Bulletin #2; Applied Biosystems).
 Immunocytochemical Analyses of EBs 
 EBs were fixed in 4% paraformaldehyde at RT for 40 min. Af-
terwards, EBs were treated with 0.2% Triton X-100 (Merck) for 15 
min for nuclear staining and then blocked with 1% BSA at RT for 
1 h. Whole EBs were stained with the primary antibody at 4   °   C 
overnight. The following primary antibodies were used: rat anti-
Oct3/4 (1: 50, R&D), rabbit anti-T (1: 50, Abcam), rat anti-Cxcr4
(1: 50, R&D) and rabbit anti-Foxa2 (1: 50, Chemicon). The EBs 
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were incubated with the secondary antibodies (diluted in 0.5% 
BSA) Alexa 488-conjugated rabbit anti-rat IgG or Alexa 488-con-
jugated chicken anti-rabbit (both 1: 100, Molecular Probes) at 
37  °  C for 45 min.
 Paraffin sections of EBs were dried at 56  °  C overnight. Depar-
affination was carried out twice in xylol for 10 min, once in 100, 
98 and 70% in ETOH, each for 5 min. After washing in water, the 
sections were boiled in Retrievagen solution (BD) for 10 min. The 
cooled sections were blocked with 1% BSA at RT for 30 min. The 
sections were incubated with the antibodies rabbit anti-E-cad-
herin (1: 50, Santa Cruz) and goat anti-N-cadherin (1: 50, Santa 
Cruz), respectively, at RT for 2 h, or with rat anti-Cxcr4 (1: 50, 
R&D), rabbit anti-T (1: 50, Abcam) and rabbit anti-Ngn3 (1: 50, 
Abcam), respectively, at 37   °   C for 30 min. Staining with anti-
Hnf1  (1: 100, Santa Cruz) and anti-Sox9 (1: 250, Santa Cruz) was 
performed at 4   °   C overnight. The secondary antibodies Alexa 
488-conjugated chicken anti-rabbit, Alexa 488-conjugated don-
key anti-goat, Alexa 488-conjugated rabbit anti-rat and Alexa 
488-conjugated chicken anti-rabbit (all 1: 200, Molecular Probes, 
diluted in 0.5% BSA) were used at 37  °  C for 30 min.
 To label the nuclei, the EBs were incubated at RT with 5   g/ml 
Hoechst 33342 for 5 min. EBs were analyzed with the confocal 
laser scanning microscope LSM-510 META (Carl Zeiss) or the 
BZ-8000 fluorescence microscope (Keyence).
 Tissue taken from whole mouse embryos, embryonic liver
and brain on embryonic day 13 (E13) and adult pancreases
served as controls (see online supplementary figure 1, www. 
 karger.com/doi/10.1159/000329864). Hematoxylin/eosin (H&E) 
staining was performed according to conventional methods.
 Results 
 Time-Dependent Sox17 Expression Monitored via 
dsRed Immunofluorescence 
 CGR8 cells carrying a homologous dsRed-IRES-puro-
mycin knock-in within the  Sox17 locus allowed the anal-
ysis of DE-specific Sox17 expression on the basis of the 
dsRed reporter. After differentiating ES cells in EBs in the 
presence of 50 ng/ml activin A, clearly visible dsRed/
Sox17-positive cells appeared at day 7, whereas control 
cells (cultured in IMDM/F12 + 20% FCS) differentiating 
without activin A showed only very few Sox17-positive 
cells ( fig. 1 a). At day 8, the number of Sox17-positive cells 
clearly increased forming large clusters ( fig. 1 a), reached 
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 Fig. 1. Differentiation analysis of Sox17-expressing cells from mu-
rine ES cells in the absence (control) or presence of activin A.
 a Sox17-dsRed labeling in control and activin A (50 and 100 ng/
ml)-treated EBs at days 7, 8 and 9.  b Gating parameters for FACS 
selection of control (left) and activin A-treated samples (right) at 
day 9.  c Percentage of FACS-selected dsRed/Sox17-positive cells in 
the entire cell population of control and activin A-treated samples 
at days 7, 8 and 9, n = 3.  d Percentage of Sox17-dsRed-positive cells 
after treatment with activin A and the ALK inhibitor SB431542. 
 e–h Transcript levels of Sox17, Sdf1, Pax6 and Meox1 in cells after 
treatment with activin A, with or without supplementation of the 
ALK inhibitor SB431542.  i Percentage of Sox17-dsRed-positive cells 
differentiated in IMDM/F12 + 20% FCS, CDM alone, or CDM sup-
plemented with 20% FCS with or without activin A (compared to 
cells treated with activin A in CDM without FCS), n = 3.  j Tran-
script levels of Sox17, Sdf1, Pax6 and Meox1 after differentiation in 
IMDM/F12 + 20% FCS, CDM alone, CDM supplemented with 20% 
FCS with or without activin A and CMD with activin A. d = Day. 
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a maximum at days 9–10 and declined within the follow-
ing 2–3 days (data not shown). Comparable results were 
obtained with 100 ng/ml activin A.
 To quantify the number of Sox17-positive progenitors, 
cells were analyzed by FACS. To discriminate viable from 
nonviable cells, dissociated cells of EBs were additionally 
stained with PI.  Figure 1 b shows the gating parameters 
used to determine Sox17-positive cells. The control cell 
population ( fig. 1 b, left) was mostly composed of dsRed-
negative cells. Only a small fraction of Sox17-positive/PI-
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negative cells was detectable. In contrast, activin A-treat-
ed cells displayed a high percentage of dsRed/Sox17-pos-
itive cells ( fig. 1 b, right).
 Whereas control cells after day 7 did not reach
amounts beyond those of 2% dsRed/Sox17-positive cells, 
activin A-treated cells attained levels up to 19% after 
treatment with 50 ng/ml activin A, and up to 16% with 
100 ng/ml activin A ( fig. 1 c). Treatment of EBs with ac-
tivin A in the presence of SB431542, an inhibitor of trans-
forming growth factor-  1 superfamily ALK receptors, al-
most completely abolished the number of dsRed/Sox17-
positive cells ( fig.  1 d), and the Sox17 mRNA level was 
downregulated ( fig.  1 e). However, Pax6 ( fig.  1 g) tran-
scripts were slightly elevated and Sdf1 and Meox1 ( fig. 1 f, 
h) levels were not changed.
 Because comparable Sox17 transcript levels in cells 
treated with 50 and 100 ng/ml activin A were detected, 
the following experiments were mainly performed with 
50 ng/ml activin A. Culturing cells in CDM alone or 
CDM supplemented with 20% FCS, with or without ac-
tivin A, resulted in very low numbers of dsRed/Sox17-
positive cells ( fig.  1 i). While control EBs showed high 
Sdf1 and Meox1 levels, cells cultured in CDM revealed 
high Pax6 transcript levels. Cells differentiated in CDM 
supplemented with 20% FCS, with and without activin A, 
displayed no Sox17, Sdf1, Pax6 or Meox1 mRNA ( fig. 1 j).
 Analyses of Lineage-Specific Transcripts during
in vitro Differentiation 
 To determine the stages of maximal expression, tran-
script levels of endo-, ecto-, and mesoderm-specific genes 
as well as markers of the early pancreatic lineage were 
analyzed by quantitative RT-PCR during in vitro differ-
entiation. Endoderm- and mesendoderm-specific tran-
scripts showed maximum levels at days 7 and 8, whereas 
most of the pancreas-specific markers revealed highest 
levels at days 9 and 10 ( fig. 2 ).
 Analyses of Lineage-Specific Proteins during in vitro 
Differentiation 
 ES cells differentiating as EBs in the absence or pres-
ence of activin A showed different protein abundance 
over time. Brachyury (T) protein was detected through-
out differentiation in control cells ( fig. 3 a–c) with only 
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occasional colocalization with Sox17 ( fig.  3 c, inset). In 
activin A-treated cells, T was coexpressed with Sox17 
only in some cells at day 7, while others stained positive 
exclusively for T ( fig. 3 d). At day 8, activin A-treated cells 
showed either T-labeling ( fig. 3 e, inset) or Sox17-labeling 
( fig. 3 e), whereas at day 9, T protein was absent ( fig. 3 f).
 Cxcr4 protein was present in control and activin A-
treated cells throughout differentiation ( fig. 3 g–i). In con-
trols, Cxcr4 labeling was rarely accompanied by Sox17 
staining (inset, fig. 3 h), while in activin A-treated cells, 
most of the Cxcr4-positive cells were also Sox17-positive 
( fig. 3 j–l). Foxa2 protein could not be detected in control 
cells ( fig. 3 m–o), but was clearly visible in activin A-in-
duced cells at day 7, diminished at day 8 and was virtu-
ally absent at day 9 ( fig. 3 p–r). 
 Transcript and Protein Levels of the
Pluripotency-Associated Marker Oct4 
 Oct4  (Pou5f1) transcripts, highly abundant in undif-
ferentiated ES cells, showed decreased levels in both con-
trol and activin A-treated cells during differentiation 
( fig. 4 a). However, some Oct4 mRNA was still detected in 
activin A-induced cells, albeit lower than in the controls 
at days 9 and 10. FACS-isolated fractions of Sox17-posi-
tive cells isolated on day 8 and day 9/10 revealed only 
marginal levels or an absence of Oct4 mRNA, whereas 
Oct4 was present in the Sox17-negative population in 
control and activin A-treated cells ( fig. 4 b). Immunofluo-
rescence analyses revealed Oct4-positive cells in the con-
trol population at days 8 and 9 ( fig. 4 c, panel 1, 2), where-
as in activin A-treated EBs positively labeled by Sox17, 
Oct4 was not detectable ( fig. 4 c, panel 3, 4). In very rare 
cases, Oct4-positive EBs could be found after treatment 
with activin A. However, these EBs were never Sox17-
positive.
 Characterization of the FACS-Selected Sox17-Positive 
Cell Population at Day 8 and Day 9/10 
 FACS analysis allowed the characterization of tran-
script profiles of Sox17-positive and Sox17-negative cell 
populations by quantitative RT-PCR at day 8 and day 9/10 
( fig. 5 ).
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 First, endoderm-specific Sox17, Foxa2 and Cxcr4 
mRNA levels were analyzed. As expected, Sox17, Foxa2 
and Cxcr4 levels were low or undetectable in the Sox17-
negative fractions at day 8 and day 9/10. The highest tran-
script levels of all three genes were found in Sox17-posi-
tive cells treated with 50 ng/ml activin A at day 8, where-
as 100 ng/ml resulted in lower levels.
 Next, the primitive/extraembryonic endoderm-spe-
cific markers Sox7, Afp and Sdf1 were analyzed. Sox7 
transcripts were generally higher in Sox17-positive than 
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in Sox17-negative fractions, but Sox7 was lower at day 
9/10 compared to day 8, and activin A-treated cells 
showed lower levels than the controls. Afp mRNA was 
highly detectable in Sox17-negative and Sox17-positive 
control cells at day 8, but almost absent in the activin A-
induced population, and in both fractions at day 9/10. In 
contrast, Sdf1 transcripts were not detectable at day 8, but 
at day 9/10. Whereas at day 9/10, the Sox17-negative frac-
tion showed similar Sdf1 mRNA levels in control and ac-
tivin A-treated cells, Sox17-positive cells showed lower 
levels in activin A-treated samples.
 T, Foxf1 and Meox1 were analyzed as characteristic 
markers of mesendoderm and mesoderm, respectively.
T was generally expressed at higher levels in activin A-
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Fig. 6. Analysis of epithelial/duct-like 
structures in EBs at day 9 of culture.
 a H&E staining of control and activin A 
(50 ng/ml)-treated cells.  b Confocal im-
ages of E-cadherin-, N-cadherin-, Brachy-
ury (T)- and Cxcr4-labeled cells (green) in 
control and activin A-treated cells in ad-
dition to nuclear staining with Hoechst 
33342 (blue). Bar = 20   m.
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treated than in control cells at both stages. Transcript lev-
els were higher in cells at day 8 in comparison to day 9/10. 
Foxf1 mRNA was not detected in activin A-treated cells, 
but was clearly measured in control cells of the Sox17-
negative (day 8) and Sox17-positive fractions (day 9/10). 
Meox1 transcripts were almost undetectable in activin 
A-treated cells, but were measured in Sox17-positive con-
trol cells at day 9/10.
 Pax6 and NeuroD6 were analyzed as ectoderm-specif-
ic markers. Pax6 transcripts were almost absent in the 
Sox17-positive fraction, but were present in the Sox17-
negative population with higher levels in activin A-treat-
ed cells than in controls. NeuroD6 mRNA was highly 
abundant in control cells of the Sox17-positive fraction, 
but downregulated in activin A-treated cells, whereas in 
Sox17-negative samples, a maximum level was detected 
in cells treated with 100 ng/ml activin A at day 8.
 Hnf4  , a marker of the primitive gut, showed remark-
able transcript levels in activin A-treated cells of the 
Sox17-positive cell fraction, but was undetectable in all 
Sox17-negative fractions at day 8 and day 9/10. Hes1, an-
other marker of early pancreatic and exocrine progeni-
tors [Kopinke et al., 2011], was highly expressed in both 
the positive and negative fractions, at day 9/10.
 Progenitor cells of the posterior foregut are character-
ized by  Pdx1 and  Ptf1a expression [Van Hoof et al., 2009]. 
Activin A-treated cells of the Sox17-positive fraction re-
vealed increased Pdx1 mRNA levels compared to control 
cells with a maximum at day 9/10, whereas Pdx1 was al-
most absent in Sox17-negative cells at both stages. Ptf1a 
mRNA was almost absent in activin A-treated cells, and 
showed higher transcript levels in control cells at day 
9/10.
 Nkx6.1, Nkx2.2, and Ngn3 transcripts were analyzed 
as characteristic markers of pancreatic endoderm and en-
docrine progenitors [Kroon et al., 2008; Van Hoof et al., 
2009]. Nkx6.1 showed maximum mRNA levels in activin 
A-treated cells of the Sox17-positive fractions, but low 
levels were detected in Sox17-negative samples. Nkx2.2 
mRNA levels were rather low in activin A-treated cells of 
both fractions, with higher levels being detected in con-
trol cells of the Sox17-positive fraction at day 8. Ngn3 
showed low levels in activin A-treated cells of the Sox17-
positive cell fraction, but high transcript levels in the 
Sox17-negative control population at day 8.
 Formation of Epithelial/Duct-Like Structures in
EBs after Activin A Treatment 
 H&E staining of control and activin A-treated EBs 
performed at day 9 revealed the presence of epithelial/
duct-like structures almost exclusively in the activin A-
treated samples ( fig. 6 a). Immunocytochemical analyses 
of EBs showed that the activin A-treated cells were posi-
tive for E-cadherin, but almost negative for N-cadherin 
( fig. 6 b), whereas control cells showed the opposite pat-
tern. Likewise, T was abundant in control cells, but absent 
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in activin A-treated EBs. Activin A-treated cells showed 
Cxcr4 labeling throughout the whole EB, but in control 
EBs only occasionally Cxcr4-positive duct-like structures 
were found. Additionally, Sox9, Hnf1  and Ngn3 were 
analyzed ( fig. 6 c). While Sox9 and Hnf1  were not de-
tectable in control EBs, both markers were abundant in 
activin A-treated EBs. Ngn3 protein was detected in con-
trol and activin A-treated cells, but the morphology of 
Ngn3-positive cells varied between both variants. Where-
as control cells showed short prolongations resembling a 
neural-like morphology, activin A-treated cells showed 
Ngn3-positive cells within the epithelial-/duct-like struc-
tures.
 Discussion 
 ES cells offer an almost unlimited source for the gen-
eration of pancreatic cells usable for cell replacement 
strategies and/or in vitro test systems. This requires the 
effective formation of DE, which in turn gives rise to all 
pancreatic lineages. However, current differentiation 
protocols suffer from their inefficiency to produce homo-
geneous DE populations. We used ES cells carrying a ho-
mologous dsRed-IRES-puromycin knock-in within the 
SOX17 gene locus to generate DE cells. This experimental 
model allowed the rapid selection of DE cells by FACS 
and the characterization of Sox17-positive cells at the 
transcript and protein level. Our data suggest the poten-
tial of Sox17-positive cells to develop into the pancreatic 
lineage by further differentiation induction.
 Activin A-Induced Differentiation of Murine ES Cells 
into DE 
 Treatment of ES-derived EBs with 50 ng/ml activin A 
under serum-free conditions resulted in an increased 
number of dsRed/Sox17-expressing DE cells, whereas 
control cells, differentiated in IMDM/F12 + 20% FCS, 
CDM alone or CDM supplemented with 20% FCS with or 
without activin A, revealed only marginal differentiation 
into DE. A comparison to wild-type ES cells showed a 
slightly delayed differentiation into DE of the transgenic 
ES cells and reduced levels of Sox17 expression due to the 
loss of one Sox17 allele. However, in contrast to Sox17 
heterozygosity in vivo [Kanai-Azuma et al., 2009], which 
leads to neonatal lethality, the loss of one Sox17 allele in 
the transgenic cells does not change the differentiation 
modality in general. Treatment with higher activin A 
concentrations (100 ng/ml) did not further enhance the 
number of Sox17-positive cells. These findings confirm 
earlier data of DE induction in ES cells by activin A [Kubo 
et al., 2004; D’Amour et al., 2006; Cai et al., 2007; Kroon 
et al., 2008] and are in accordance with previous results 
showing that concentrations of at least 30 (and below 100) 
ng/ml activin A are required for DE induction in murine 
[Kubo et al., 2004] and human [Shim et al., 2007] ES cells, 
respectively. Abolishment of Sox17 expression upon ad-
dition of the ALK inhibitor SB431542 underlined that the 
effect seen in this study can be unequivocally attributed 
to the activin A induction. We further showed that ac-
tivin A-induced Sox17-positive cells are Oct4-negative.
 Time-Dependent Expression of Developmental 
Control Genes during Activin A Treatment 
 Sox17 is essential for the formation of DE [Tam et al., 
2003], which is severely impaired in Sox17 mutant mice 
[Kanai-Azuma et al., 2002]. In activin A-treated cells 
Sox17 expression peaked at day 8 of differentiation. Sus-
tained treatment with activin A for more than 10 days did 
not perpetuate Sox17 expression.  Sox17 expression was 
preceded by the expression of Foxa2, necessary for the 
development of gut [Weinstein et al., 1994] and early pan-
creatic epithelium [Gittes, 2009]. Early expression of 
Foxa2 is a prerequisite for successful differentiation into 
the endocrine lineage, plays a major role in the matura-
tion of endocrine cells [Lee et al., 2002, 2005] and is nec-
essary for Pdx1 expression in   -cells [Gerrish et al., 2000; 
Sund et al., 2001]. In contrast to Foxa2 and Sox17, Cxcr4 
(specifically expressed in DE and mesoderm, but not
extraembryonic endoderm [McGrath et al., 1999]) was 
expressed throughout differentiation. Although Cxcr4 
transcripts were present in both control and activin A-
treated cells, immunocytochemical analyses revealed 
clear differences between the two populations. In control 
cells, Cxcr4 was not colocalized with Sox17 labeling indi-
cating the mesodermal nature of Cxcr4-positive cells (be-
cause Sox17 is not expressed in the mesoderm [Kanai-
Azuma et al., 2002]). In activin A-treated cells, Cxcr4 was 
localized in Sox17-positive cells confirming their deriva-
tion from DE.
 The derivation of DE was further substantiated by 
downregulated transcript levels of primitive/visceral en-
doderm-specific Sox7, Afp and Sdf1. At the stage of max-
imal Sox17 expression, all three markers were only weak-
ly expressed in activin A-treated cells, but strongly abun-
dant in the controls. Specifically, the increased Sdf1 level 
in control cells from days 8 to 10 could point towards
mesoderm differentiation, because Sdf1 also serves as a 
marker for mesoderm [D’Amour et al., 2005]. The expres-
sion pattern of Brachyury (T) suggests that these cells 
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transit through a mesendoderm progenitor stage and ac-
quire DE characteristics between days 8 and 9. The ac-
tivin A-specific endoderm induction is further substanti-
ated by transcript downregulation of the mesoderm-spe-
cific marker genes  Meox1 and  Foxf1 .
 Because activin A/nodal signaling can also induce 
neural differentiation [Iwasaki et al., 1996; Rolletschek et 
al., 2006], we determined neural-specific Pax6 and Neu-
roD6 levels. They were almost completely downregulated 
in activin A-treated cells, but were detectable in the con-
Table 1.  Primer sets employed for real-time RT-PCR analysis
Gene Primer sequence (5–3)
Sox17
(NM_011441)
AGA AAC TGC AGA CCA GAA GCT ATC A (s)
GCT CAT TGT ATC CAT GAG GTG ACA (as)
Cxcr4
(NM_009911)
ACC TCT ACA GCA GCG TTC TCA TC (s)
TGT TGG TGG CGT GGA CAA T (as)
Foxa2
(NM_010446)
GAA CTC CAT CCG CCA CTC TCT (s)
AGC CCT TGC CAG GCT TGT (as)
Sox7
(NM_011446)
GCC AAG GAT GAG AGG AAA CGT (s)
ATG ACT TTC CCA GCA TCT TGC T (as)
Afp
(NM_007423)
TCG ACC TCA CCG GGA AGA T (s)
TCA CCA CAG CCG GAC CAT (as)
Sdf1
(NM_001012477)
GCA CCA CGG TCT CCA TCC T (s)
AAT ATT GCC AGG TGA GGG TAG TG (as)
Oct4
(NM_013633)
GCA GCT CAG CCT TAA GAA CAT GT (s)
TCT CAT TGT TGT CGG CTT CCT (as)
Brachyury (T)
(NM_009309)
TGC TGC AGT CCC ATG ATA ACT G (s)
TAT GAC TCA CAG GCA GCA TGC T (as)
Pax6
(NM_013627)
GCA ACA CTC CTA GTC ACA TTC CTA TC (s)
TTG GTG AGG GCG GTG TCT (as)
NeuroD6
(NM_009717.2)
CAG GGT GCC ATG TTC AGG TT (s)
GAG ATT GGC TGC GCA GAT GT (as)
Pdx1
(NM_010491)
GTT GGG TAT AGC CGG AGA GAT G (s)
TTG GAG CCC AGG TTG TCT AAA (as)
Ngn3
(NM_009719)
TGA CTG ACC TGC TGC TCT CTA TTC T (s)
TCC GGG AAA AGG TTG TTG TG (as)
Hnf4a
(NM_008261)
ACG TGC TGC TCC TAG GCA AT (s)
GAT GGA CAC ACG GCT CAT CTC (as)
Nkx6.1
(NM_144955)
TTC GGA GAA TGA GGA GGA TGA (s)
GCT GCC ACC GCT CGA TT (as)
Nkx2.2
(NM_010919)
GCC GAC ACA GGT CAA GAT CTG (s)
GCG TCA CCT CCA TAC CTT TCT C (as)
Ptf1a
(NM_018809)
AGG CCC AGA AGG TTA TCA TCT G (s)
GAA AGA GAG TGC CCT GCA AGA (as)
Meox1
(NM_010791)
CCT CAG GGC TGT CCC ATT ATC (s)
GCT CGT TGA AGA TTC GCT CAG T (as)
Foxf1
(L35949)
CGG AGA AGC CGC CCT ACT (s)
GCG CGC CTG AAG AAA CTG (as)
Hes1
(NM_008235)
CGG CTT CAG CGA GTG CAT (s)
CGG TGT TAA CGC CCT CAC A (as)
trols. Our data underline that the activin A concentration 
used was able to inhibit ectoderm differentiation, con-
firming the results of Shim et al. [2007].
 Hnf4  , a marker of primitive gut and extraembryonic 
endoderm [Duncan et al., 1994], showed distinct patterns 
in control and activin A-treated samples. The early
Hnf4  transcript appearance in control cells (days 7–8), 
parallel to high levels of Sox7, Afp and Sdf1, underlined 
the extraembryonal nature of Hnf4  -positive cells, 
whereas in activin A-treated cells, Hnf4  transcripts 
were not present before day 9, when extraembryonic 
markers were low. We may conclude that Hnf4  -positive 
cells of the activin A-treated population do not belong to 
extraembryonic lineages. The Foxa2 transcript maxi-
mum preceding Hnf4  expression is in line with the in-
duction of  Hnf4  expression by Foxa2 [Ryffel, 2001].
 Hes1, a marker of both pancreatic and exocrine pro-
genitors [Kopinke et al., 2011], may be attributed to mul-
tipotent pancreatic progenitors. We could speculate that 
Hes1 transcripts in ES and control cells are correlated to 
neuronal commitment and differentiation, because Hes1 
is also expressed in neural stem cells [Qu and Shi, 2009].
 Pdx1, significant for pancreatic development, is ex-
pressed in a biphasic pattern with highest expression at 
E9.5–10 and E18 in the mouse [Soria, 2001]. During early 
development, Pdx1 correlates with Foxa2 expression. We 
also observed a biphasic pattern of Pdx1 transcript levels 
with peaks at day 7 and day 10, respectively, and found 
that Pdx1 coincided with maximal Foxa2 and Ptf1a lev-
els.  Ptf1a expression is induced by  Pdx1 and is a prereq-
uisite for exocrine development of the pancreas [Bonal 
and Herrera, 2008]. Stanger et al. [2007] found that the 
number of Pdx1-positive cells between E8.5 and E12.5 
determines the final size of the pancreas. Given the max-
imum Pdx1 levels at days 7 and 10, the in vitro differen-
tiation pattern is thought to mimic the in vivo develop-
ment and substantiates the role of Pdx1 in the devel-
opment of insulin-producing cells [Stoffers et al., 1997; 
Dutta et al., 1998]. Mimicking the biphasic pattern of 
Pdx1 expression was a prerequisite of inducing endocrine 
pancreatic cell phenotypes [Bernardo et al., 2009].
 The potential formation of pancreatic endoderm of ac-
tivin A-treated cells is reflected by increased Nkx6.1 and 
Nkx2.2 transcript levels. Both Nkx2.2 and Nkx6.1 are 
crucial for pancreatic   -cell development. Nkx2.2-null 
mice failed to develop   -cells [Sussel et al., 1998], and loss 
of Nkx6.1 function led to a decrease in   -cell mass [Sand-
er et al., 2000].
 Ngn3, the key transcription factor of endocrine differ-
entiation [Gu et al., 2002], showed a biphasic pattern sim-
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ilar to Pdx1 in activin A-treated cells. In contrast, in the 
controls, the high transcript levels of Ngn3, but also of 
Pax6, NeuroD6 and Hes1 may be due to neural commit-
ment of feeder-free ES cells, because these genes are also 
expressed in developing neural cells [Lee et al., 2003; Rol-
letschek et al., 2006].
 Characterization of Selected Sox17-Positive Cell 
Populations at Day 8 and Day 9/10 
 ES cells differentiating via EBs generally result in a 
mixed cell population. Sox17-positive cells were selected 
at 2 time points, with maximal Sox17 mRNA levels (day 
8) and maximal Sox17 protein abundance (day 9/10). 
Cells at both stages (day 9/10) were collectively analyzed, 
because of almost no differences in transcript levels.
 The concordant patterns of endoderm-, mesendo-
derm- and mesoderm-specific transcripts of activin A-
induced Sox17-positive cells at day 8 and day 9/10 pro-
vided evidence for a transient progression through a 
mesendoderm progenitor stage.
 The transcript pattern of mesodermal genes in control 
cells was different in Sox17-positive and Sox17-negative 
cells at day 8 and day 9/10. While Foxf1 showed maximal 
levels in the Sox-17-negative fraction at day 8, Meox1 and 
Foxf1 were upregulated in the Sox17-positive population 
at day 9/10. These data would be in line with findings that 
Sox17 is also associated with hematopoiesis and vascular 
development [Kim et al., 2007; Liao et al., 2009], although 
there is evidence that two different promoters drive Sox17 
expression in the endoderm and vascular lineage. Be-
cause Foxf1 acts also as a vasculogenic factor by activat-
ing Bmp4 (which in turn promotes the assembly of vas-
cular tubes from mesodermal progenitors [Astorga and 
Carlsson, 2007]), the Sox17/Foxf1-positive fraction of 
control cells at day 9/10 may represent cells determined 
to vasculogenesis. 
 The downregulation of mesoderm-specific transcripts 
paralleled by the lack and/or downregulation of neuroec-
toderm-specific Pax6 and NeuroD6 mRNA, respectively, 
confirmed the activin A-induced differentiation into the 
endoderm lineage.
 DE differentiation characterized by Sox17, Foxa2 and 
Cxcr4 transcripts was generally higher in the activin A-
treated Sox17-positive populations than in the controls. 
The same was true for the primitive gut marker Hnf4  
and the posterior foregut marker Pdx1. In general, poste-
rior foregut progenitors are characterized by coexpres-
sion of  Pdx1 and  Ptf1a [Oliver-Krasinski and Stoffers, 
2008]. Therefore, it was surprising that compared to the 
relatively high Pdx1 levels in the activin A-treated Sox17-
positive fraction at day 9/10, only low Ptf1a levels were 
detected. However, in the foregut,  Pdx1 is expressed in a 
much broader region than  Ptf1a , and  Pdx1 expression is 
not dependent on  Ptf1a expression [Gittes, 2009]. This 
interpretation would also be supported by the observa-
tion that in  Ptf1a- null mice, although acini and ducts 
were lacking, endocrine cells developed [Krapp et al., 
1998; Lin et al., 2004].
 The high Ngn3 levels in the Sox17-negative control 
population at day 8 may be due to neuronal rather than 
endocrine pancreatic differentiation. This is substanti-
ated by the lack of DE markers in this fraction, but  Ngn3 
expression in neuronal progenitors [Sommer et al., 1996]. 
Neural commitment of control cells was also demonstrat-
ed by Ngn3-positive neural-like cell types ( fig. 6 ), where-
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 Fig. 7. Summary of the characteristics of Sox17-positive cell pop-
ulations after activin A treatment showing differentiation of ES 
cells (ESC) into cells of the endoderm and early pancreatic lin-
eage. Dashed lines represent differentiation pathways inhibited by 
activin A. 
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as in activin A-treated cells, Ngn3 labeling was almost 
exclusively restricted to epithelial/duct-like structures.
 Nkx6.1, a marker of pancreatic progenitors [Gittes, 
2009], is preceded by  Pdx1 expression during pancreas 
development. Based on relatively high Pdx1 levels in ac-
tivin A-treated cells at day 7, it is not surprising that 
Nkx6.1 showed highest levels in the Sox17-positive frac-
tion at day 8 and day 9/10. Because  Nkx6.1 expression is 
later restricted to insulin-positive cells and supports   -
cell function [Sander et al., 2000], this finding would fur-
ther support our hypothesis that via selection of Sox17-
positive progenitors, insulin-producing, but also exo-
crine and ductal cells could be generated ( fig. 7 ).
 The formation of epithelial/duct-like structures in ac-
tivin A-treated EBs labeled by epithelial (E-cadherin) and 
not mesenchymal (N-cadherin) markers, but by Ngn3-
labeled epithelial structures, excludes a neuronal origin. 
We may hypothesize that these cells represent early pan-
creatic progenitors. This would be further corroborated 
by the presence of Ngn3-positive ductal epithelial cell 
clusters in activin A-treated cells, which are also labeled 
by Sox9 and Hnf1  , known as key mediators of Ngn3-
positive pancreatic endocrine progenitors [Gittes, 2009].
 In summary, activin A-treated Sox17-positive cells are 
committed to the pancreatic endocrine fate and poten-
tially capable of further differentiation into the pancre-
atic lineage in vitro, whereas control cells are also com-
mitted to mesodermal and neuroectodermal differentia-
tion.
 Conclusion 
 Treatment of murine ES cells with activin A and sub-
sequent selection of the Sox17-positive population en-
abled the generation of cells that are committed to estab-
lish a pancreatic endoderm and endocrine fate as sum-
marized in  figure 7 . By reducing the heterogeneity of the 
ES cell progeny, Sox17-expressing cells are a suitable 
model to address fundamental issues in more detail, in-
cluding the evaluation of growth and differentiation fac-
tors and culture conditions to delineate the pancreatic 
differentiation process and to generate endocrine and 
exocrine pancreatic cells in vitro. According to McKnight 
et al. [2010] and Wang et al. [2011], the system we present 
here fulfills one requirement for successful pancreatic 
differentiation of ES cells.
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